BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22782504)

  • 1. Loss of expression of the differentially expressed in adenocarcinoma of the lung (DAL-1) protein is associated with metastasis of non-small cell lung carcinoma cells.
    Zhang Y; Xu R; Li G; Xie X; Long J; Wang H
    Tumour Biol; 2012 Dec; 33(6):1915-25. PubMed ID: 22782504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
    Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
    Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DAL-1 attenuates epithelial to mesenchymal transition and metastasis by suppressing HSPA5 expression in non-small cell lung cancer.
    Qiu X; Guan X; Liu W; Zhang Y
    Oncol Rep; 2017 Nov; 38(5):3103-3113. PubMed ID: 29048640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration.
    Arora S; Ranade AR; Tran NL; Nasser S; Sridhar S; Korn RL; Ross JT; Dhruv H; Foss KM; Sibenaller Z; Ryken T; Gotway MB; Kim S; Weiss GJ
    Int J Cancer; 2011 Dec; 129(11):2621-31. PubMed ID: 21448905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
    Zhang X; Zhang X; Yu B; Hu R; Hao L
    Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.
    Navab R; Liu J; Seiden-Long I; Shih W; Li M; Bandarchi B; Chen Y; Lau D; Zu YF; Cescon D; Zhu CQ; Organ S; Ibrahimov E; Ohanessian D; Tsao MS
    Neoplasia; 2009 Dec; 11(12):1292-300. PubMed ID: 20019837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
    Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
    Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
    Zhang MY; Lin J; Kui YC
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of FURIN by prostaglandin-endoperoxide synthase 2 in lung epithelial NCI-H292 cells.
    Brant KA; Leikauf GD
    Mol Carcinog; 2014 Mar; 53(3):192-200. PubMed ID: 23065687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer.
    Yu J; Bulk E; Ji P; Hascher A; Tang M; Metzger R; Marra A; Serve H; Berdel WE; Wiewroth R; Koschmieder S; Müller-Tidow C
    Clin Cancer Res; 2010 Apr; 16(8):2275-83. PubMed ID: 20371680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 promotes invasion of NSCLC via suppression of CDH1.
    Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
    J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 5-aza-2'-deoxycytidine on cell proliferation of non- small cell lung cancer cell line A549 cells and expression of the TFPI-2 gene.
    Dong YQ; Liang JS; Zhu SB; Zhang XM; Ji T; Xu JH; Yin GL
    Asian Pac J Cancer Prev; 2013; 14(7):4421-6. PubMed ID: 23992014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
    Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer.
    Chen X; Guan X; Zhang H; Xie X; Wang H; Long J; Cai T; Li S; Liu Z; Zhang Y
    J Exp Clin Cancer Res; 2015 Jan; 34(1):3. PubMed ID: 25609022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
    Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
    Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
    Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.